Guest guest Posted February 19, 2006 Report Share Posted February 19, 2006 I have been trying for over 12 months to get a sympathetic GP or Consultant to prescribe LDN as an off-licence, informed consent medication with no luck to date. Because I continued to ask the questions I was referred to our National Hospital for Neurology (used to be 'Nervous Diseases')to see an eminent Professor in the field. As expected, I suppose, the bottom line response is " I cannot support or recommend any treatment which has not been the subject of clinical trials and published research " . Consequently at times of overspent budgets on NHS prescriptions, there is no chance of me getting a prescribing practitioner locally. The really sad thing is that this applies to all treatments including stem cell thertapy even though Cambridge is well advanced, or even the world leader, in the development of 'Regenerative Medicine'. I was offered Amantedine as an attempt to deal with fatigue but on reading his note to my GP snd the comment " has not YET become incontinent " , that's not all I have to worry about! Does any one have experience of taking LDN at the same time as Amantedine? (Perhaps I will persue Advanced Cell Therapeutics anyway. 19,000 Euros is after all, only money and I understand that they will offer a rebate in certain cases.) The good news is that I have been invited to trials on new medication designed to stop the progress of the disease and this will involve a minimum of 5 MRI scans over 2 or 3 years. It will probably also mean that I have to NOT take LDN even if I can get it from MedsMex and compound it myself. The good second bit of news is that if the first trial is unsuccsessful, I have been offered a second trial of a cannabinoid derivitive! Roll on I say! Iain Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.